MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults

/PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announces the first...

Related Keywords

Denmark ,South Africa ,United Kingdom ,Belgium ,Copenhagen ,Køavn ,London ,City Of ,Danish ,Lidia Oostvogels ,Isabel Leroux Roels ,Paul Heath ,Centre For Vaccinology ,Groupb Streptococcus ,St George Vaccine Institute ,Lund University ,Lancefield Groupb Streptococcus ,Minervax Aps ,Chief Medical Officer ,Principal Investigator ,Older Adults ,Vaccine Institute ,Lead Investigator ,Minervax ,